Revonto 20 mg/60mL
dantrolene sodium · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ProPharma Distribution
Revonto is an injectable form of dantrolene sodium used to treat malignant hyperthermia, a serious pharmacogenetic condition that can occur during surgery and anesthesia. It works by reducing muscle contractions and heat production in the body during a malignant hyperthermia crisis.
Key Facts
- Brand Name
- Revonto
- Generic Name
- dantrolene sodium
- NDC Code (Product)
84549-003- Manufacturer
- ProPharma Distribution
- Strength
- 20 mg/60mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA078378
- Marketing Start
- 04/09/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Revonto used for?
Revonto is an injectable form of dantrolene sodium used to treat malignant hyperthermia, a serious pharmacogenetic condition that can occur during surgery and anesthesia. It works by reducing muscle contractions and heat production in the body during a malignant hyperthermia crisis.
Is Revonto a controlled substance?
Revonto is not classified as a controlled substance by the DEA.
What is the generic name for Revonto?
The generic name for Revonto is dantrolene sodium. There are 10 other brand versions of dantrolene sodium.
What is the NDC code for Revonto 20 mg/60mL?
The NDC (National Drug Code) for Revonto 20 mg/60mL is 84549-003, listed by ProPharma Distribution.
Other Revonto Dosages
Other Dantrolene Brands
See all →- dantrolene sodium25 mg/149884-362
- Dantrolene Sodium100 mg/10115-4433
- Dantrolene Sodium25 mg/172162-2045
- dantrolene sodium50 mg/149884-363
- Dantrolene Sodium25 mg/150268-217
- dantrolene sodium50 mg/163629-2169
- Dantrolene Sodium50 mg/172162-2046
- dantrolene sodium25 mg/163629-2168
- dantrolene sodium100 mg/170518-4622
- dantrolene sodium25 mg/172162-1497
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)